We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2010 by Assaf-Harofeh Medical Center.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01255202
First Posted: December 7, 2010
Last Update Posted: December 7, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Assaf-Harofeh Medical Center
  Purpose
The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.

Condition
Preeclampsia/Toxemia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Longitudenal Study in the Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Resource links provided by NLM:


Further study details as provided by Assaf-Harofeh Medical Center:

Biospecimen Retention:   Samples Without DNA
serum and urine

Estimated Enrollment: 200
Study Start Date: September 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
twin preganacies

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
women with twin preganacy undergoing nuchal scan in our department
Criteria

Inclusion Criteria:

  • a women with a vaiable twin pregnany

Exclusion Criteria:

  • women with thrombophilya
  • women terated with anticoagolant
  • women with vascular disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01255202


Contacts
Contact: Ran Svirsky, MD 972-8-9779000 rsvirs@gmail.com

Locations
Israel
Assaf Harofe Medical Center Recruiting
Zrifin, Israel
Contact: Ran Svirsky, MD    972-8-9779000    rsvirs@gmail.com   
Principal Investigator: Ran Svirsky, MD         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
  More Information

Responsible Party: Svirsky Ran, Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier: NCT01255202     History of Changes
Other Study ID Numbers: 189/09
First Submitted: December 5, 2010
First Posted: December 7, 2010
Last Update Posted: December 7, 2010
Last Verified: December 2010

Keywords provided by Assaf-Harofeh Medical Center:
preeclampsia
toxemia
twin
pregnancy
pp13
prediction
kongo red

Additional relevant MeSH terms:
Pre-Eclampsia
Toxemia
Sepsis
Hypertension, Pregnancy-Induced
Pregnancy Complications
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes